/EINPresswire.com/ -- SYDNEY, AUSTRALIA -- (Marketwired) -- 06/23/16 -- Simavita Limited ("Simavita" or the "Company") (TSX VENTURE: SV)(ASX: SVA) is pleased to announce the results of the Special Meeting of the Company's shareholders which was held at 10:00 am today (Australian Eastern Standard Time) in Sydney, Australia. All nine resolutions that were put before the meeting were passed on a show of hands. Details of the proxy votes received by the Company in relation to each resolution in the notice of special meeting and information circular are attached.

For further information, please check our website (www.simavita.com).

About Simavita

Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ incontinence diagnostic tool kit which is an instrumented incontinence assessment application that provides evidence based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect record and report incontinence events during a compulsory or recommended assessment period in residential aged care sites to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

                              SIMAVITA LIMITED
                             SPECIAL MEETING OF
                              SHAREHOLDERS HELD
                              ON JUNE 23, 2016

                                PROXY RESULTS

        RESOLUTIONS                        NUMBER OF SHARES

                                  FOR   AGAINST  ABSTAIN   EXCLUDED NON VOTE
1.  Approval and           55,646,847    29,444    5,127          0        0
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds

2.  Approval and           17,481,916    34,244    5,127 38,160,131        0
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Dussman Pty. Ltd.

3.  Approval and           55,614,047    32,244    5,127     30,000        0
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Holland Family Trust

4.  Approval and           55,644,047    32,244    5,127          0        0
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Bingham Investments
     Pty. Ltd.

5.  Approval and           55,642,047    34,244    5,127          0        0
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for the
     Michael Brown
     Superannuation Fund

6.  Approval and           45,739,319    41,571        0  9,900,528        0
     Authorization of the
     issuance of up to
     138,740,000 CDIs

7.  Approval and           54,476,323   995,429  109,666          0  100,000
     Authorization to
     grant to Mr. Michael
     Spooner up to
     7,603,422 unlisted
     options

8.  Approval and           54,576,323   995,429  109,666          0        0
     Authorization to
     grant to Dr. Gary
     Pace up to 7,603,422
     unlisted options

9.  Approval and           49,405,237 5,840,046  433,485          0    2,650
     Authorization to
     increase the total
     amount of potential
     aggregate directors'
     fees which may be
     paid to non-executive
     directors

                      SIMAVITA LIMITED
                     SPECIAL MEETING OF
                      SHAREHOLDERS HELD
                      ON JUNE 23, 2016

                        PROXY RESULTS

        RESOLUTIONS            PERCENTAGE OF VOTES CAST

                                 FOR    AGAINST    WITHHELD/
                                                     ABSTAIN
1.  Approval and              99.94%      0.05%        0.01%
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds

2.  Approval and              99.78%      0.20%        0.03%
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Dussman Pty. Ltd.

3.  Approval and              99.93%      0.06%        0.01%
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Holland Family Trust

4.  Approval and              99.93%      0.06%        0.01%
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for
     Bingham Investments
     Pty. Ltd.

5.  Approval and              99.93%      0.06%        0.01%
     Authorization of the
     operation of the
     Conversion Mechanism
     in the Convertible
     Note Deeds for the
     Michael Brown
     Superannuation Fund

6.  Approval and              99.91%      0.09%        0.00%
     Authorization of the
     issuance of up to
     138,740,000 CDIs

7.  Approval and              98.01%      1.79%        0.20%
     Authorization to
     grant to Mr. Michael
     Spooner up to
     7,603,422 unlisted
     options

8.  Approval and              98.02%      1.79%        0.20%
     Authorization to
     grant to Dr. Gary
     Pace up to 7,603,422
     unlisted options

9.  Approval and              88.73%     10.49%        0.78%
     Authorization to
     increase the total
     amount of potential
     aggregate directors'
     fees which may be
     paid to non-executive
     directors

Contacts:
Simavita Limited
Ms Peta Jurd
+61 421 466 653
pjurd@simavita.com
www.simavita.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.